Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 344,069 |
|
|||||
| News | (2) | ||||||
| Day High | 1.15 | Low High |
|||||
| Day Low | 1.01 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Aptevo Therapeutics Inc | APVO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.135 | -11.64% | 1.025 | 16:30:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.12 | 1.01 | 1.15 | 1.025 | 1.16 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,247 | 344,069 | $ 1.06 | $ 363,140 | - | 0.67 - 80.96 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:21:23 | 5 | $ 1.05 | USD |
Aptevo Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 544.13k | 533.46k | - | 0 | -17.41M | -32.64 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Aptevo Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical APVO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.7274 | 1.38 | 0.725 | 1.09 | 7,054,055 | 0.2976 | 40.91% |
| 1 Month | 3.025 | 3.10 | 0.67 | 1.06 | 2,277,197 | -2.00 | -66.12% |
| 3 Months | 6.60 | 10.80 | 0.67 | 2.35 | 1,060,221 | -5.58 | -84.47% |
| 6 Months | 9.6624 | 11.4532 | 0.67 | 4.05 | 716,829 | -8.64 | -89.39% |
| 1 Year | 77.88 | 80.96 | 0.67 | 10.99 | 526,535 | -76.86 | -98.68% |
| 3 Years | 1,042.80 | 1,397.44 | 0.67 | 394.21 | 579,384 | -1,041.78 | -99.90% |
| 5 Years | 36.08 | 2,640.00 | 0.67 | 410.67 | 579,531 | -35.06 | -97.16% |
Aptevo Therapeutics Description
| Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells. |
